Se connecter S'abonner en ligne
  • Infos sociétés
  • Infos OPCVM
  • Alertes e-mail
  • Notre offre
 Langues  Par thème  Par secteur d'activité  Par pays
NervGen Pharma [CA64082X2032]   
[08/09/2022]

NervGen Pharma : Has The Controversy Around Falsified Alzheimer's Research Impacted The Path To Finding The Cure?

DGAPNews: NervGen Pharma Has The Controversy Around Falsified Alzheimers Research Impacted The Path To Finding The Cure? 08.09.2022 / 22:47 CET/CEST The issuer is solely responsible for the content of this announcement. Finding the cure to Alzheimer’s has confounded researchers for decades.As a disease, Alzheime... Lire le communiqué
 


Vidéos
Gestionnaires,
Emetteurs,
Ma sélection
Les communiqués les plus lus de NervGen...